- Home
- HURN vs CPRX Comparison
HURN vs CPRX Comparison
Compare HURN & CPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HURN
- CPRX
- Stock Information
- Founded
- HURN 2002
- CPRX 2002
- Country
- HURN United States
- CPRX United States
- Employees
- HURN N/A
- CPRX N/A
- Industry
- HURN Professional Services
- CPRX Biotechnology: Pharmaceutical Preparations
- Sector
- HURN Consumer Discretionary
- CPRX Health Care
- Exchange
- HURN Nasdaq
- CPRX Nasdaq
- Market Cap
- HURN 2.4B
- CPRX 2.6B
- IPO Year
- HURN 2004
- CPRX 2006
- Fundamental
- Price
- HURN $140.70
- CPRX $19.97
- Analyst Decision
- HURN Strong Buy
- CPRX Strong Buy
- Analyst Count
- HURN 4
- CPRX 5
- Target Price
- HURN $171.50
- CPRX $33.20
- AVG Volume (30 Days)
- HURN 188.7K
- CPRX 1.5M
- Earning Date
- HURN 10-28-2025
- CPRX 11-05-2025
- Dividend Yield
- HURN N/A
- CPRX N/A
- EPS Growth
- HURN 37.96
- CPRX 183.96
- EPS
- HURN 5.74
- CPRX 1.65
- Revenue
- HURN $1,556,665,000.00
- CPRX $558,499,000.00
- Revenue This Year
- HURN $13.32
- CPRX $16.51
- Revenue Next Year
- HURN $8.31
- CPRX $9.58
- P/E Ratio
- HURN $24.59
- CPRX $12.14
- Revenue Growth
- HURN 9.24
- CPRX 28.55
- 52 Week Low
- HURN $102.95
- CPRX $19.15
- 52 Week High
- HURN $155.00
- CPRX $26.58
- Technical
- Relative Strength Index (RSI)
- HURN 55.79
- CPRX 45.00
- Support Level
- HURN $135.79
- CPRX $19.60
- Resistance Level
- HURN $142.26
- CPRX $20.75
- Average True Range (ATR)
- HURN 3.81
- CPRX 0.76
- MACD
- HURN 0.17
- CPRX 0.02
- Stochastic Oscillator
- HURN 50.08
- CPRX 30.19
About HURN Huron Consulting Group Inc.
Huron Consulting Group Inc is a professional services firm. The company provides expertise in technology, operations, advisory services, & analytics through three operating segments namely Healthcare, Education, and Commercial. Healthcare segment helps the firms to transform and innovate the delivery model to focus on patient wellness by improving quality outcomes, minimizing care variation and fundamentally improving patient and population health, Education segment provides management consulting and technology solutions, and Commercial segment is focused on serving industries and organizations facing disruption and regulatory change. It generates a majority of its revenue from the Healthcare Segment.
About CPRX Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone).